Page 19 - மருந்தியல் ஆபத்து மதிப்பீடு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Saturday, April 10, 2021, 09:27 GMT+7 A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. Photo: Reuters Europe’s drug regulator said on Friday it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine. The European Medicines Agency’s safety committee has also been looking at how AstraZeneca’s COVID-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca’s vaccine. Johnson & Johnson (J&J) said it was aware of the rare reports of blood clots in individuals given its COVID-19 vaccine, and was working with regulators to assess the data and provide relevant information.

United statesUnited kingdomGeorgetown universityDistrict of columbiaJesse goodmanIan douglasPharmacovigilance risk assessment committeeLondon school of hygiene tropical medicineUs centers for diseaseDrug administrationEuropean medicines agencyDisease controlLondon schoolTropical medicineஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்